Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000157

Chairperson & CEO sold 9,500 shares at an average $541.64 ($5,145,537)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-05 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-05 Sale : show line 2 in the form 10b5-1 −501 $536.26 $268,665 333,442 I
2026-10-05 Sale : show line 3 in the form 10b5-1 −905 $537.43 $486,373 332,537 I
2026-10-05 Sale : show line 4 in the form 10b5-1 −655 $538.62 $352,795 331,882 I
2026-10-05 Sale : show line 5 in the form 10b5-1 −931 $539.50 $502,279 330,951 I
2026-10-05 Sale : show line 6 in the form 10b5-1 −1,028 $540.50 $555,633 329,923 I
2026-10-05 Sale : show line 7 in the form 10b5-1 −1,239 $541.66 $671,120 328,684 I
2026-10-05 Sale : show line 8 in the form 10b5-1 −918 $542.56 $498,067 327,766 I
Open-market sales · 9,500 sh · avg $541.64 · $5,145,537

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-05 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 299,910 I
Loading xslF345X06/primarydocument.xml…